Company / Share Buybacks
Theravance Biopharma, Inc. Share Buybacks History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Share Buybacks
$445.0K
FY2024
5-year range
$445.0K / $197.1M
FY2022-FY2024
Trend
-99.8%
vs FY2023
Sector context
#41 of 48
Health Care
What the data says
Theravance Biopharma, Inc.'s share buybacks of $445,000 is lower than 85% of companies in the Health Care sector (FY2024). Declined from $129M to $445,000 over the past 2 years.
Based on SEC 10-K filings.
$445,000 in FY2024.
Declined from $129M to $445,000 over the past 2 years.
Health Care sector context is included.
Share Buybacks over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 15% in Health CareTop 85% of 48This company $445.0K Sector average $611.9M
▼
-99.9% below sector average
Key checks
Key Insights
- In FY2024, share buybacks decreased 99.8% year-over-year.
- Ranks #41 out of 48 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Share BuybacksValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $445.0K | -99.8% |
| FY2023 | $197.1M | +53.0% |
| FY2022 | $128.8M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026